Portal de investigación
ENSAYO CLINICO DE TENOFOVIR EN PROFILAXIS DE PACIENTES HEMATOLOGICOS ANTI-HBC POSITIVO Y AGHBS NEGATIVO EN TRATAMIENTO CON RITUXIMAB ( ESTUDIO PREBLIN).
Datos básicos
- Código:
- REM-TEN-2011-01
- Protocolo:
- REM-TEN-2011-01
- EUDRACT:
- 2011-000905-30
- NCT:
- Centro:
- Dotación:
- Año de incio:
- Año de finalización:
Documentos
- No hay documentos
Participantes
Financiadores - Promotores
Resultados del Ensayo Clínico
[Translated article] Cybersecurity: a priority for pharmacy services in the age of artificial intelligence
Marin, Cayetano M. Hernandez, Monte-Boquet, Emilio, Andres, Jose Luis Poveda
Editorial Material. 10.1016/j.farma.2024.08.009. 2024
[Translated article] Good humanisation practices in the healthcare of patients with rare diseases in Pharmacy Services
Company Albir MJ, Andrés JLP, Solsona MDE
Article. 10.1016/j.farma.2023.10.004. 2024
[Translated article] New challenges in advanced therapies.
Megías-Vericat JE; (...); Poveda Andrés JL
Article. 10.1016/j.farma.2024.05.001. 2024
[Translated article] Pharmacokinetic-guided switching from standard half-life factor VIII to extended half-life pegylated factor VIII in haemophilia A therapy in clinical practice.
Chovi-Trull, Maria; (...); Andres, Jose Luis Poveda
Article. 10.1016/j.farma.2024.12.007. 2025
[Translated article] Real-world effectiveness and safety of nivolumab in patients with relapsed or refractory classical Hodgkin lymphoma.
Fernandez, Laura Lorente; (...); Andres, Jose Luis Poveda
Article. 10.1016/j.farma.2024.09.006. 2024
In vitro personalised model based on induced pluripotent stem cells for studying idiosyncratic hepatotoxicity
Pelecha, M.; (...); Tolosa, L.
Meeting Abstract. 10.1016/j.toxlet.2024.07.291. 2024
18F-FDG-PET/CT response after first-line treatment as a prognostic factor for survival in peripheral T-cell lymphoma: a Spanish retrospective study.
Cordoba, Raul; (...); Martin Garcia-Sancho, Alejandro
Article. 10.1080/17474086.2024.2313457. 2024
A Century of Progress on Wilson Disease and the Enduring Challenges of Genetics, Diagnosis, and Treatment.
Penning, Louis C.; (...); Weiskirchen, Ralf
Article. 10.3390/biomedicines11020420. 2023
A Descriptive Study of 103 Primary Cutaneous B-Cell Lymphomas: Clinical and Pathological Characteristics and Treatment from the Spanish Lymphoma Oncology Group (GOTEL).
Martínez-Banaclocha N; (...); Gumà J
Article. 10.3390/cancers16051034. 2024
A multicentre ambispective observational study into the incidence and clinical management of aplastic anaemia in Spain (IMAS study)
Vallejo C; (...); Codesido ML
Article. 10.1007/s00277-023-05602-x. 2024
A multicriteria decision analysis (MCDA) applied to three long-term prophylactic treatments for hereditary angioedema in Spain
Zozaya, Neboa; (...); Hidalgo-Vega, Alvaro
Article. 10.33393/grhta.2022.2333. 2022
A multi-criteria decision analysis on the value of nintedanib for interstitial lung diseases.
Zozaya, Neboa; (...); Verde, Luis
Article. 10.1017/S0266462322000459. 2022
A randomized phase II study comparing consolidation with a single dose of Y-90 ibritumomab tiuxetan vs. maintenance with rituximab for two years in patients with newly diagnosed follicular lymphoma responding to R-CHOP. Long-term follow-up results
Lopez-Guillermo, Armando; (...); Tomas, Jose Francisco
Article. 10.1080/10428194.2021.1971216. 2021
A simple score to predict early severe infections in patients with newly diagnosed multiple myeloma
Encinas, Cristina; (...); Martinez-Lopez, Joaquin
Article. 10.1038/s41408-022-00652-2. 2022
Access to liver transplant for women in Spain: a national registry analysis
Tejedor Bravo, Marta; (...); Berenguer, Marina
Meeting Abstract. 2023
Access to liver transplant for women in Spain: a national registry analysis
Tejedor, M.; (...); Berenguer, M.
Meeting Abstract. 2023
Adaptation and validation of an abbreviated version of the SIPAT integrated psychosocial risk scale in patients with liver cirrhosis candidates for liver transplantation (SIPAT-11).
Garcia Morales, Natalia; (...); Cubiella, Joaquin
Article. 10.1016/j.gastrohep.2024.502220. 2024
Addition of chemotherapy to nivolumab after PD-1 inhibitor failure as bridge to allogeneic stem cell transplantation in classical Hodgkin's lymphoma: report on three cases and literature review
Review. 10.1177/20406207211038181. 2021
Addressing the Burden and Management Strategies for Disparities and Inequities Among Liver Transplant Professionals: The ILTS Experience.
Andacoglu, Oya; (...); Selzner, Nazia
Article. 10.3389/ti.2023.11240. 2023
Adjuvanted recombinant zoster vaccine in adult autologous stem cell transplant recipients: polyfunctional immune responses and lessons for clinical practice
Stadtmauer, Edward A.; (...); ZOE-SCT Study Grp Collaborators
Article. 10.1080/21645515.2021.1953346. 2021
An international, multicenter, survey-based analysis of practice and management of acute liver failure.
Gurakar, Ahmet; (...); Coilly, Audrey
Article. 10.1097/LVT.0000000000000402. 2024
Analysis of chemical contamination by hazardous drugs with BD HD Check(R) system in a tertiary hospital
Valero García S; (...); Poveda Andrés JL
Article. 10.1177/10781552211038518. 2021
Anesthesia and Critical Care for the Prediction and Prevention for Small-for-size Syndrome: Guidelines from the ILTS-iLDLT-LTSI Consensus Conference.
Chadha, Ryan; (...); Rela, Mohamed
Article. 10.1097/TP.0000000000004803. 2023
Are MELD and MELDNa Still Reliable Tools to Predict Mortality on the Liver Transplant Waiting List?
Tejedor, Marta, Selzner, Nazia, Berenguer, Marina
Article. 10.1097/TP.0000000000004163. 2022
Assessing the value of moderate-to-severe atopic dermatitis treatment using multi-criteria decision analysis (MCDA).
Pereyra-Rodríguez JJ; (...); Ortiz de Frutos FJ
Letter. 10.1111/jdv.19432. 2023
Autologous stem cell transplantation as consolidation of first-line chemotherapy in patients with peripheral T-cell lymphoma: a multicenter GELTAMO/FIL study.
García-Sancho AM; (...); Caballero D
Article. 10.3324/haematol.2021.279426. 2022
Automated Whole-Liver MRI Segmentation to Assess Steatosis and Iron Quantification in Chronic Liver Disease.
Martí-Aguado D; (...); Martí-Bonmatí L
Article. 10.1148/radiol.2021211027. 2022
Avatrombopag in immune thrombocytopenia: A real-world study of the Spanish ITP Group (GEPTI).
Pascual-Izquierdo C; (...); Mingot-Castellano ME
Article. 10.1002/ajh.27498. 2024
Baricitinib against severe COVID-19: effectiveness and safety in hospitalised pretreated patients.
Iglesias Gómez R; (...); Poveda Andrés JL
Article. 10.1136/ejhpharm-2021-002741. 2021
Bioavailability of once-daily tacrolimus formulations used in clinical practice in the management of De Novo kidney transplant recipients: the better study.
Fernandez Rivera C; (...); Hernandez D
Article. 10.1111/ctr.14550. 2022
Brain abscesses in early post-liver transplantation.
Minguez Sabater, Alejandro; (...); Prieto Castillo, Martin
Article. 10.1016/j.eimce.2021.09.007. 2021
Budesonide as first-line treatment in patients with autoimmune hepatitis seems inferior to standard predniso(lo)ne administration.
Diaz-Gonzalez, Alvaro; (...); Londoño MC
Article. 10.1097/HEP.0000000000000018. 2023
CA125: a new biomarker in patients with Fontan circulation (vol 76, pg 112, 2023)
Fuentes, Francisco Buendia; (...); Soriano, Joaquin Rueda
Correction. 10.1016/j.rec.2023.03.018. 2023
CA125: a new biomarker in patients with Fontan circulation.
Fuentes, Francisco Buendia; (...); Soriano, Joaquin Rueda
Article. 10.1016/j.rec.2022.05.029. 2022
Can endothelial biomarkers before liver transplantation together with classical cardiovasculat risk factors be useful to predict cardiovascular risk after liver transplantation
Herreras Lopez, Julia; (...); Aguilera Sancho, Victoria
Meeting Abstract. 2022
Can endothelial biomarkers before LT together with classical cardiovascular risk factors be useful to predict cardiovascular risk after LT?
Herreras, J.; (...); Aguilera, V.
Article. 2022
CD8+ NKs as a potential biomarker of complete response and survival with lenalidomide plus R-GDP in the R2-GDP-GOTEL trial in recurrent/refractory diffuse large B cell lymphoma.
Hontecillas-Prieto L; (...); de la Cruz-Merino L
Article. 10.3389/fimmu.2024.1293931. 2024
Circulating MicroRNAs: Dynamic Markers of Liver Transplant Injury.
Mas VR, Bardhi E, Berenguer M
Article. 10.1097/TP.0000000000003816. 2021
Cirrhosis is associated with lower serological responses to COVID-19 vaccines in patients with chronic liver disease.
Simao, Andre Lopes; (...); Castro, Rui E
Article. 10.1016/j.jhepr.2023.100697. 2023
Clinical benefits of a Bayesian model for plasma-derived factor VIII/VWF after one year of pharmacokinetic-guided prophylaxis in severe/moderate hemophilia A patients
Megias-Vericat, JE; (...); Poveda, JL
Article. 10.1016/j.thromres.2021.07.009. 2021
Clinical presentation, causative drugs and outcome of patients with autoimmune features in two prospective DILI registries.
Garcia-Cortes, Miren; (...); Andrade, Raul J.
Article. 10.1111/liv.15623. 2023
CMV reactivation (rCMV) is associated with lower hepatocellular carcinoma (HCC) recurrence after liver transplatatoin (LT)
Aguilera, V.; (...); Berenguer, M.
Meeting Abstract. 2023
CMV reactivation after liver transplantation (LT) in HIV infected is similar to non-HIV patients: a single center comparative study
Garcia-Garcia, Sonia; (...); Aguilera Sancho, Victoria
Meeting Abstract. 2023
CMV reactivation is associated with lower hepatocellular carcinoma (HCC) recurrence after liver transplantation (LT)
Aguilera Sancho, Victoria; (...); Berenguer, Marina
Meeting Abstract. 2022
COBALT: A Confirmatory Trial of Obeticholic Acid in Primary Biliary Cholangitis With Placebo and External Controls.
Kowdley KV; (...); Villamil A
Article. 10.14309/ajg.0000000000003029. 2024
Consensus recommendations for the improvement of inter- and intra-centre care coordination in the management of hemophilia.
Montoro-Ronsano JB; (...); Soto-Ortega I
Article. 10.1016/j.farma.2023.01.003. 2023
Consensus recommendations for the improvement of inter- and intra-centre care coordination in the management of hemophilia.
Montoro-Ronsano, Jose Bruno; (...); Soto-Ortega, Inmaculada
Article. 10.1016/j.farma.2023.04.002. 2023
Correction to COBALT: A Confirmatory Trial of Obeticholic Acid in Primary Biliary Cholangitis With Placebo and External Controls.
Kowdley, Kris V; (...); Villamil, Alejandra
Article. 10.14309/ajg.0000000000003153. 2024
COST-EFFECTIVENESS ANALYSIS OF DIFELIKEFALIN FOR THE TREATMENT OF CHRONIC KIDNEY DISEASE ASSOCIATED-PRURITUS IN SPAIN
Sanchez-Alvarez, Emilio E.; (...); Hernaez Colque, M.
Meeting Abstract. 2024
COVID vaccination among liver transplant recipients: A EASL-ESOT/ELITA-ILTS multi society survey
Vinaixa, Carmen; (...); Berenguer, Marina
Meeting Abstract. 2022
COVID vaccination among liver transplant recipients: an EASL-ESOT/ELITA-ILTS multi-society international survey
Vinaixa, C.; (...); Berenguer, M.
Meeting Abstract. 2022
Cumulative exposure to tacrolimus and incidence of cancer after liver transplantation
Rodriguez-Peralvarez, Manuel; (...); Gomez Bravo, Miguel Angel
Meeting Abstract. 2022
Cybersecurity, a priority for pharmacy services in the age of artificial intelligence.
Hernández Marín CM, Monte-Boquet E, Poveda Andrés JL
Editorial Material. 10.1016/j.farma.2024.08.001. 2024
Cytokine response as a biomarker for early diagnosis and outcome prediction of stem cell transplant recipients and acute leukemia patients with invasive aspergillosis.
Puerta-Alcalde, Pedro; (...); Garcia-Vidal, Carolina
Article. 10.1093/mmy/myac038. 2022
Cytomegalovirus reactivation is associated with lower hepatocelullar carcinoma recurrence rates after liver transplantation
Aguilera Sancho, Victoria; (...); Rodriguez-Peralvarez, Manuel
Meeting Abstract. 2023
CYTOMEGALOVIRUS SPECIFIC POLYFUNCTIONAL T-CELL RESPONSES EXPRESSING CD107A ASSOCIATED WITH CONTROL OF CMV REACTIVATION AFTER LIVER TRANSPLANTATION
Carvalho-Gomes, A; (...); Aguilera, V
Meeting Abstract. 2021
Cytomegalovirus specific polyfunctional T-cell responses expressing CD107a predict control of CMV infection after liver transplantation.
Carvalho-Gomes Â; (...); López-Labrador FX
Article. 10.1016/j.cellimm.2021.104455. 2022
Cytomegalovirus specific polyfunctional T-cells control CMV reactivation after liver transplantation
Carvalho-Gomes, A; (...); Aguilera, V
Meeting Abstract. 2021
Cytomegalovirus specific polyfunctional t-cells control CMV reactivation, after liver transplantation
Carvalho-Gomes, Angela; (...); Sancho, Victoria Aguilera
Meeting Abstract. 2024
Characteristics and impact of sex in a cohort of patients with primary sclerosing cholangitis: Experience of a transplant center in the Mediterranean basin.
Mínguez Sabater A; (...); Berenguer, Marina
Article. 10.1016/j.gastrohep.2021.03.017. 2022
CHARACTERISTICS AND IMPACT OF SEX IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS: A MULTICENTER STUDY FROM A CLASSICALLY LOW PREVALENCE AREA
Minguez, Alejandro; (...); Berenguer, Marina
Meeting Abstract. 2021
Characteristics and trends of liver transplantation in a cohort of patients with primary sclerosing cholangitis: a retrospective multicenter study
Minguez, A.; (...); Berenguer, M.
Meeting Abstract. 2022
Characteristics, trends and outcomes of liver transplantation (LT) for primary sclerosing cholangitis (PSC) in female patients: analysis of the European Liver Transplantation Registry (ELTR)
Di Maira, T; (...); European Liver & Intestine
Meeting Abstract. 2021
Characteristics, Trends, and Outcomes of Liver Transplantation for Primary Sclerosing Cholangitis in Female Versus Male Patients: An Analysis From the European Liver Transplant Registry
Berenguer M; (...); European Liver Intestine Transplan
Article. 10.1097/TP.0000000000003542. 2021
Characterization of drug-induced liver injury associated with drug reaction with eosinophilia and systemic symptoms in two prospective DILI registries.
Medina-Caliz, Inmaculada; (...); Alvarez-Alvarez, Ismael
Article. 10.1007/s00204-023-03630-0. 2023
Chronic liver disease-associated severe thrombocytopenia in Spain: Results from a retrospective study using machine learning and natural language processing.
Calleja-Panero, Jose Luis; (...); Gonzalez Calvo, Jose
Article. 10.1016/j.gastrohep.2023.05.010. 2023
Deciphering predictive factors for choice of thrombopoietin receptor agonist, treatment free responses, and thrombotic events in immune thrombocytopenia (vol 11, 16867, 2021)
Lozano, Maria L.; (...); Vicente, Vicente
Article. 10.1038/s41598-021-95732-x. 2021
Design and rationale for a real-world prospective, multicenter registry of myocardial revascularization failure and secondary revascularization: The REVASEC study.
Salinas P; (...); Escaned J
Article. 10.1016/j.carrev.2021.11.015. 2021
Determining value in the treatment of activated PI3Kdelta syndrome in Spain: a multicriteria decision analysis from the perspective of key stakeholders.
Abad, Maria Reyes; (...); Gil, Alicia
Article. 10.33393/grhta.2024.3041. 2024
Determining what represents value in the treatment of prurigo nodularis and its key unmet needs in Spain through Multi-Criteria Decision Analysis
Silvestre, Juan Francisco; (...); Serra-Baldrich, Esther
Article. 10.1002/jvc2.275. 2024
Development and Validation of a Scoring System to Predict Response to Obeticholic Acid in Primary Biliary Cholangitis (vol 22, pg 2062, 2024)
De Vincentis, A.; (...); Conde, Isabel
Correction. 2025
Development and validation of a scoring system to predict response to obeticholic acid in primary biliary cholangitis.
De Vincentis, Antonio; (...); Carbone, Marco
Article. 10.1016/j.cgh.2024.05.008. 2024
Development and validation of an image biomarker to identify metabolic dysfunction associated steatohepatitis: MR-MASH score
Marti-Aguado, David; (...); Marti-Bonmati, Luis
Article. 10.1111/liv.15766. 2024
Digital Pathology Enables Automated and Quantitative Assessment of Inflammatory Activity in Patients with Chronic Liver Disease.
Marti-Aguado, David; (...); Marti-Bonmati, Luis
Article. 10.3390/biom11121808. 2021
Does colectomy improve survival in patients with ulcerative colitis undergoing liver transplant for autoimmune liver diseases?
Trapero-Marugan, M.; (...); Cuervas-Mons, V.
Meeting Abstract. 2023
Early liver transplantation for acute alcoholic hepatitis In a spanish liver transplant center
Aguilera Sancho, Victoria; (...); Berenguer, Marina
Meeting Abstract. 2023
Early predictors of corticosteroid response in acute severe autoimmune hepatitis: A nationwide multicenter study
Tellez, Luis; (...); Albillos, Agustin
Article. 10.1111/apt.16926. 2022
Economic Impact of European Liver and Intestine Transplantation Association (ELITA) Recommendations for Hepatitis B Prophylaxis After Liver Transplantation.
Cortesi, Paolo Angelo; (...); Belli, Luca Saverio
Article. 10.3389/ti.2023.10954. 2023
Editorial: Infectious diseases and hematology: diagnosis and management
Gonzalez-Lopez, Tomas Jose; (...); Di Micco, Pierpaolo
Editorial Material. 10.3389/fmed.2024.1385874. 2024
EFFECTIVENESS AND SAFETY OF SECOND-LINE THERAPY IN PRIMARY BILIARY CHOLANGITIS (PBC): A PROSPECTIVE MULTICENTER REAL-WORLD COHORT
Gomez-Dominguez, Elena; (...); Fernandez-Rodriguez, Conrado
Meeting Abstract. 2023
Effectiveness of Caplacizumab Nanobody in Acquired Thrombotic Thrombocytopenic Purpura Refractory to Conventional Treatment
Palanques-Pastor T; (...); Poveda Andrés JL
Article. 10.1159/000517813. 2021
EFFICACY AND SAFETY OF BUDESONIDE AS FIRST LINE TREATMENT IN PATIENTS WITH AUTOIMMUNE HEPATITIS: SPANISH MULTICENTER STUDY
Diaz-Gonzalez, Alvaro; (...); Carlota Londono, Maria
Meeting Abstract. 2021
EFFICACY OF OBETICHOLIC ACID (OCA) VS PLACEBO AND EXTERNAL CONTROL (EC) ON CLINICAL OUTCOMES IN PRIMARY BILIARY CHOLANGITIS (PBC)
Kowdley, Kris V.; (...); Villamil, Alejandra
Meeting Abstract. 2023
Eltrombopag Added to Immunosuppression in Severe Aplastic Anemia.
Peffault de Latour R; (...); Risitano AM
Article. 10.1056/NEJMoa2109965. 2022
ELTROMBOPAG ADDED TO STANDARD IMMUNOSUPPRESSION IMPROVES RESPONSE RATE IN SEVERE APLASTIC ANEMIA: RESULTS OF THE MULTICENTER PHASE III PROSPECTIVE RANDOMIZED RACE TRIAL
Risitano, A. M.; (...); de latour, R. Peffault
Meeting Abstract. 2021
ELTROMBOPAG ADDED TO STANDARD IST IS SUPERIOR TO IST ALONE AS FRONT-LINE TREATMENT FOR SEVERE APLASTIC ANEMIA: FINAL 2-YEAR ANALYSIS OF EBMT-SAAWP RACE STUDY
Risitano, Antonio Maria; (...); de Latour, Regis Peffault
Meeting Abstract. 2024
Enhanced recovery after surgery programs improve short-term outcomes after liver transplantation-A systematic review and meta-analysis
Tinguely, Pascale; (...); Spiro, Michael
Article. 10.1111/ctr.14453. 2021
Enhanced recovery for liver transplantation: recommendations from the 2022 International Liver Transplantation Society consensus conference.
Pollok, Joerg M.; (...); Spiro, Michael
Article. 10.1016/S2468-1253(22)00268-0. 2023
Ertapenem neurotoxicity in liver transplantation.
Martinez Delgado, Sara; (...); Conde, Isabel
Article. 10.17235/reed.2021.8469/2021. 2022
ESOT Consensus Platform for Organ Transplantation: Setting the Stage for a Rigorous, Regularly Updated Development Process.
Cillo U; (...); Selzner N
Review. 10.3389/ti.2022.10915. 2022
European Society for Organ Transplantation Consensus Statement on Biomarkers in Liver Transplantation.
Berenguer M; (...); Zubair H
Article. 10.3389/ti.2023.11358. 2023
Everolimus plus minimized tacrolimus on kidney function in liver transplantation: REDUCE, a prospective, randomized controlled study.
Gómez-Bravo M; (...); Santoyo J
Article. 10.17235/reed.2022.8549/2021. 2022
Excess waitlist mortality and survival benefit of liver transplantation for patients with severe acute-on-chronic liver failure: Interim results of the CHANCE study
Gustot, Thierry; (...); Jalan, Rajiv
Meeting Abstract. 2024
Exchangeable copper for patients with Wilson disease at follow-up: rethinking normal ranges or changing methodology.
Marino, Zoe; (...); Berenguer, Marina
Article. 10.1097/HEP.0000000000001105. 2024
EXCHANGEABLE COPPER QUANTIFICATION FELLS BELOW NORMAL RANGE IN A HIGH PROPORTION OF PATIENTS WITH WILSON DISEASE DURING FOLLOW-UP
Mendez, Zoe Marino; (...); Berenguer, Marina
Meeting Abstract. 2024
Exchangeable copper quantification fells belownormal range in a high proportion of patients withWilson disease during follow-up
Marino, Zoe; (...); Berenguer, Marina
Meeting Abstract. 2024
EXPERT CONSENSUS CRITERIA AND PRACTICAL RECOMMENDATIONS FOR PBC CARE IN THE COVID-19 ERA AND BEYOND
Berenguer, Marina; (...); Carbone, Marco
Meeting Abstract. 2021
Exploring pregnancy, breastfeeding and contraception among women with Wilson disease in Spain: results from the Spanish Wilson registry
Romero-Gutierrez, Marta; (...); Marino, Zoe
Meeting Abstract. 2023
External validation of models to predict hepatocellular carcinoma (HCC) in HCV SVR F3-F4 patients
Sahuco, Ivan; (...); Berenguer, Marina
Meeting Abstract. 2023
External validation of models to predict hepatocellular carcinoma in Hepatitis C Virus cured F3-F4 patients.
Carvalho-Gomes Â; (...); Berenguer M
Article. 10.1002/ueg2.12571. 2024
Fetal exposure to tofacitinib during the first trimester: A healthy newborn case report
Fernandez-Sanchez, M; (...); Poveda-Andres, JL
Article. 10.1002/bdr2.1942. 2021
FibroScan compared to liver biopsy for accurately detecting recurrent hepatic steatosis and fibrosis after liver transplantation for metabolic dysfunction-associated steatohepatitis
Martinez-Arenas, Laura; (...); Berenguer, Marina
Meeting Abstract. 2024
FibroScan compared to liver biopsy for accurately detecting recurrent hepatic steatosis and fibrosis after liver transplantation for metabolic dysfunction-associated steatohepatitis
Martinez-Arenas, L.; (...); Berenguer, M.
Meeting Abstract. 2024
FibroScan compared to liver biopsy for accurately staging recurrent hepatic steatosis and fibrosis after transplantation for MASH.
Martinez-Arenas, Laura; (...); Berenguer, Marina
Article. 10.1111/liv.16085. 2024
Final Analysis of the Phase 2 ELM-2 Study: Odronextamab in Patients with Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL)
Ayyappan, Sabarish; (...); Prince, H. Miles
Meeting Abstract. 10.1182/blood-2023-179818. 2023
First nationwide genetic study on Wilson disease (Spanish Wilson registry): high diversity in mutations and in use of genetic evaluation, association with clinical data and influence on diagnosis and health costs
Alonso Castellano, Pablo; (...); Garcia-Villarreal, Luis
Meeting Abstract. 2023
Fostamatinib effectiveness and safety for immune thrombocytopenia in clinical practice.
Gonzalez-Lopez, Tomas Jose; (...); Garcia-Donas Gabaldon, Gloria
Article. 10.1182/blood.2024024250. 2024
Frailty and Sarcopenia in Acute-on-Chronic Liver Failure
Renau, LP; (...); Berenguer M
Article. 10.1002/hep4.1722. 2021
Frailty changes after liver transplantation in the Spanish setting. Results from a Spanish multicentre prospective cohort study
Puchades, L.; (...); Berenguer, M.
Meeting Abstract. 2023
Frailty Changes After Liver Transplantation. Results From a Spanish Multicenter Prospective Cohort Study
Puchades, Lorena; (...); Berenguer, Marina
Article. 10.1097/TXD.0000000000001599. 2024
GEMA-Na and MELD 3.0 severity scores to address sex disparities for accessing liver transplantation: a nationwide retrospective cohort study.
Rodríguez-Perálvarez ML; (...); Gastaca M
Article. 10.1016/j.eclinm.2024.102737. 2024
GENDER AND RACIAL DISCRIMINATION AMONG LIVER TRANSPLANTATION PROFESSIONALS: A SURVEY FROM ILTS EDI COMMITTEE
Andacoglu, Oya; (...); Selzner, Nazia
Meeting Abstract. 2021
Gender and racial discrimination among liver transplantation professionals: report of a global survey
Aguilera, V.; (...); Selzner, N.
Article. 2022
Gender and Racial Disparity Among Liver Transplantation Professionals: Report of a Global Survey
Aguilera, Victoria; (...); Selzner, Nazia
Article. 10.3389/ti.2022.10506. 2022
Gender differences in liver transplantation (LT) for acute liver failure (ALF) in a multicentre ALF-LT Spanish cohort
Conde, Isabel; (...); Aguilera Sancho, Victoria
Meeting Abstract. 2023
Gender differences in liver transplantation (LT) for acute liver failure (ALF) in a multicentre ALF-LT Spanish cohort
Conde, I.; (...); Aguilera, V.
Meeting Abstract. 2023
Genetic Variants Associated with Biological Treatment Response in Inflammatory Bowel Disease: A Systematic Review.
Plaza J; (...); Moret-Tatay I
Article. 10.3390/ijms25073717. 2024
Geriatric assessment in hematology scale predicts treatment tolerability in older patients diagnosed with hematological malignancies: The RETROGAH study.
de la Rubia J; (...); Bonanad, Santiago
Article. 10.1016/j.jgo.2022.10.016. 2022
Good posttransplant outcome using donors after cardiac death (DCD) when applying strict selection criteria
de la Varga, MF; (...); Castillo, MP
Meeting Abstract. 2021
Good post-transplant outcomes using liver donors after circulatory death when applying strict selection criteria: A propensity-score matched-cohort study.
Fernandez-de la Varga, Margarita; (...); Aguilera, Victoria
Article. 10.1016/j.aohep.2022.100724. 2022
Guide to Good Humanization Practices in Patients with Rare Diseases. who vadis
Editorial Material. 2022
Healthcare Resource Utilization among Patients between 60-75 Years with Secondary Acute Myeloid Leukemia Receiving Intensive Chemotherapy Induction: A Spanish Retrospective Observational Study
Solana-Altabella, Antonio; (...); Martinez-Cuadron, David
Article. 10.3390/cancers14081921. 2022
Health-Related Quality of Life and Symptoms in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma Treated with Odronextamab Monotherapy in the Phase 2 ELM-2 Study
Iskierka-Jazdzewska, Elzbieta; (...); Ivanescu, Cristina
Meeting Abstract. 10.1182/blood-2023-180743. 2023
Health-Related Quality of Life in Patients Living with Wilson Disease in Spain: A Cross-Sectional Observational Study.
Marino, Zoe; (...); Anguera, Anna
Article. 10.3390/jcm12144823. 2023
Hepatic nerve endings are rewired by cholestatic injury to connect inflamed lymphatics to sites of ductular remodelling
Noon, Luke; (...); Lloyd, Alison
Meeting Abstract. 2023
HepatoPredict Accurately Selects Hepatocellular Carcinoma Patients for Liver Transplantation Regardless of Tumor Heterogeneity
Andrade, Rita; (...); Cardoso, Joana
Article. 10.3390/cancers17030500. 2025
Hepatorenal syndrome markedly impacts prognosis of patients with alcohol-associated hepatitis. Results from the spanish registry of alcohol-associated liver disease (REHALC)
Gratacos-Gines, Jordi; (...); Pose, Elisa
Meeting Abstract. 2024
High incidence of pulmonary thromboembolism in hospitalized SARS-CoV-2 infected patients despite thrombo-prophylaxis.
El-Qutob D; (...); Carrera-Hueso FJ
Article. 10.1016/j.hrtlng.2022.02.003. 2022
Hospital pharmacy initiatives for improving the management of patients with congenital coagulopathies
Bruno Montoro-Ronsano, Jose; (...); Alberto Vella, Vincenzo
Article. 10.7399/fh.11729. 2022
Hospitalization budget impact during the COVID-19 pandemic in Spain.
Carrera-Hueso, F. J.; (...); Crespo-Palomo, C.
Article. 10.1186/s13561-021-00340-0. 2021
How can artificial intelligence optimize value-based contracting?
Poveda, Jose Luis; (...); Medrano, Ignacio H.
Letter. 10.1186/s40545-022-00475-3. 2022
IDENTIFICATION OF CANDIDATES FOR MASLD TREATMENT WITH INDETERMINATE VIBRATION- CONTROLLED TRANSIENT ELASTOGRAPHY
Marti-Aguado, David; (...); Marti-Bonmati, Luis
Meeting Abstract. 2024
Identification of Candidates for MASLD Treatment With Indeterminate Vibration-Controlled Transient Elastography.
Marti-Aguado, David; (...); Marti-Bonmati, Luis
Article. 10.1016/j.cgh.2024.10.014. 2024
IFISTRATEGY: Spanish National Survey of Invasive Fungal Infection in Hemato-Oncologic Patients.
Vallejo, Carlos; (...); Peman, Javier
Article. 10.3390/jof9060628. 2023
Immunoparesis recovery in newly diagnosed transplant ineligible multiple myeloma patients, an independent prognostic factor that complements minimal residual disease.
Lakhwani S; (...); Hernández MT
Article. 10.1007/s00277-024-06031-0. 2024
Immunoparesis Recovery in Transplant-Ineligible Newly Diagnosis Multiple Myeloma Patients: An Independent Prognosis Factor That Could Complement Prognostic Value of Minimal Residual Disease
Lakhwani, Sunil; (...); Hernandez, Miguel-Teodoro
Meeting Abstract. 10.1182/blood-2022-166826. 2022
IMPACT OF COMORBIDITIES ON LIVER TRANSPLANTATION: A PROSPECTIVE AND MULTICENTRIC ANALYSIS
Serrano, Trinidad; (...); Salcedo, Magdalena
Meeting Abstract. 2023
Impact of comorbidities on liver transplantation: a prospective and multicentric study
Serrano, Trinidad; (...); Salcedo, Magdalena
Meeting Abstract. 2022
Impact of COVID-19 on the liver and on the care of patients with chronic liver disease, hepatobiliary cancer, and liver transplantation: an updated EASL position paper.
Marjot, Thomas; (...); Cornberg, Markus
Article. 10.1016/j.jhep.2022.07.008. 2022
Impact of Molecular Testing Using Next-Generation Sequencing in the Clinical Management of Patients with Non-Small Cell Lung Cancer in a Public Healthcare Hospital.
Simarro, Javier; (...); Palanca, Sarai
Article. 10.3390/cancers15061705. 2023
Impact of muscle mass on survival of patients with hepatocellular carcinoma after liver transplantation beyond the Milan criteria
Beumer, Berend R.; (...); IJzermans, Jan N. M.
Article. 10.1002/jcsm.13053. 2022
Impact of muscle mass on survival of patients with hepatocellular carcinoma after liver transplantation beyond the Milan criteria
Beumer, Berend; (...); Ijzermans, Jan
Meeting Abstract. 10.1002/jcsm.13053. 2022
Impact of suffering Wilson disease in Spain: an observational cross-sectional multicenter study
Marino, Zoe; (...); Anguera, Anna
Meeting Abstract. 2023
Inadequate social support decreases survival in decompensated liver cirrhosis patients.
García Morales N; (...); Cubiella, Joaquin
Article. 10.1016/j.gastrohep.2022.04.006. 2022
Incidence and prognostic impact of cancer after liver transplantation
Gastaca, M; (...); Rodriguez-Peralvarez, M
Meeting Abstract. 2021
Incidence of de novo tumors after liver transplantation (LT) in HIV infected is similar to non-HIV patients: a single center comparative study
Chafer, Isabel Terol; (...); Sancho, Victoria Aguilera
Meeting Abstract. 2023
Incidence of de novo tumors after liver transplantation (LT) in HIV infected is similar to non-HIV patients: a single center comparative study
Chafer, I. Terol; (...); Sancho-Tello, M. V. Aguilera
Meeting Abstract. 2023
Incidence of fungal and other opportunistic infections in patients with autoimmune hepatitis: a spanish multicentre study
Diaz-Gonzalez, Alvaro; (...); Crespo, Javier
Meeting Abstract. 2024
International Liver Transplantation Society Global Census report: a first look at the pediatric liver transplantation activity around the world
Lopez-Verdugo, F; (...); Pediat Liver Transplantation
Meeting Abstract. 2021
International Living Donor Liver Transplant Registry - Initial progress towards transparent reporting of outcomes
Kantsedikas, I.; (...); Rela, M.
Meeting Abstract. 2024
Is erenumab an efficient alternative for the prevention of episodic and chronic migraine in Spain? Results of a cost-effectiveness analysis.
Pozo-Rosich P; (...); Irimia P
Article. 10.1186/s10194-024-01747-w. 2024
Isavuconazole Pharmacokinetics in Critically Ill Patients: Relationship with Clinical Effectiveness and Patient Safety.
Martin-Cerezuela, Maria; (...); Ramirez Galleymore, Paula
Article. 10.3390/antibiotics13080706. 2024
Ixazomib Plus Lenalidomide/Dexamethasone (IRd) Versus Lenalidomide /Dexamethasone (Rd) Maintenance after Autologous Stem Cell Transplant in Patients with Newly Diagnosed Multiple Myeloma: Results of the Spanish GEM2014MAIN Trial
Rosinol, Laura; (...); Blade Creixenti, Joan
Meeting Abstract. 10.1182/blood-2021-146798. 2021
LATTICE radiotherapy: A one institution experience
Solero, I.; (...); Conde, A.
Meeting Abstract. 2023
Launch of the International Living Donor Liver Transplantation Outcomes Registry.
Staubli, Sebastian; (...); Rela, Mohamed
Letter. 10.1016/S2468-1253(23)00185-1. 2023
Lenalidomide and dexamethasone maintenance with or without ixazomib, tailored by residual disease status in myeloma.
Rosinol, Laura; (...); Blade, Joan
Article. 10.1182/blood.2022019531. 2023
Lenalidomide in combination with R-ESHAP in patients with relapsed or refractory diffuse large B-cell lymphoma: A phase 2 study from GELTAMO.
Martin Garcia-Sancho, A.; (...); Caballero, D.
Article. 10.1111/bjh.18989. 2023
Lenalidomide plus R-GDP (R2-GDP) in Relapsed/Refractory Diffuse Large B Cell Lymphoma. Final Results of the R2-GDP-GOTEL Trial and Immune Biomarker subanalysis.
Palaz N-Carri N, Natalia; (...); de la Cruz-Merino, Luis
Article. 10.1158/1078-0432.CCR-22-0588. 2022
Lessons from population genomics for Wilson disease: Prevalence, penetrance of mutations, clinical implications and design of regional screening programmes
Alonso Castellano, Pablo; (...); Garcia-Villarreal, Luis
Meeting Abstract. 2023
LIPID DROPLET MORPHOLOGY JUSTIFIES DISCORDANCES BETWEEN HEPATIC STEATOSIS GRADES AND MRI PROTON DENSITY FAT FRACTION
Marti-Aguado, David; (...); Marti-Bonmati, Luis
Meeting Abstract. 2024
Liver transplant for porto-sinusoidal vascular disease (psvd): long-term outcome
Magaz, M; (...); Valdig
Meeting Abstract. 2021
Liver Transplantation 2023: Status Report, Current and Future Challenges.
Terrault, Norah A; (...); Heimbach, Julie
Article. 10.1016/j.cgh.2023.04.005. 2023
LIVER TRANSPLANTATION FOR NON-ALCOHOLIC STEATOHEPATITIS: LOW PREVALENCE REGIONS ARE CATCHING UP
Martinez Arenas, Laura; (...); Berenguer, Marina
Meeting Abstract. 2022
Liver transplantation for patients with acute-on-chronic liver failure (ACLF) in Europe: Results of the ELITA/EF-CLIF collaborative study (ECLIS)
Belli, LS; (...); ELITA EF-CLIF Working Grp
Article. 10.1016/j.jhep.2021.03.030. 2021
Liver Transplantation for Porto-Sinusoidal Vascular Liver Disorder: Long-term Outcome.
Magaz, Marta; (...); Garcia-Pagan, Juan Carlos
Article. 10.1097/TP.0000000000004444. 2022
LOCATION AND ALLOCATION: INEQUITY OF ACCESS TO LIVER TRANSPLANTATION FOR PATIENTS WITH ACUTE-ON-CHRONIC LIVER FAILURE GRADE 3 (ACLF-3) ACROSS EUROPE.
Artzner, Thierry; (...); Jalan, Rajiv
Meeting Abstract. 2021
Location and allocation: inequity of access to liver transplantation for patients with severe acute-on-chronic liver failure in Europe.
Artzner, Thierry; (...); Jalan, Rajiv
Article. 10.1002/lt.26499. 2022
Long term follow-up in HCV infected patients with end stage chronic kidney disease after DAA therapy
Martinez-Camprecios, J; (...); Buti, M
Meeting Abstract. 2021
Longitudinal outcomes of obeticholic acid therapy in ursodiol-nonresponsive primary biliary cholangitis: Stratifying the impact of add-on fibrates in real-world practice.
Gomez, E; (...); Fernandez-Rodriguez, C M
Article. 10.1111/apt.18004. 2024
Long-Term Effectiveness, Safety, and Patient- Reported Outcomes of Self-Administered Subcutaneous Hepatitis B Immunoglobulin in Liver Post-Transplant Hepatitis B Prophylaxis: A Prospective Non-Interventional Study
Roche B; (...); Samuel D
Article. 10.12659/AOT.936162. 2022
Long-term follow-up of HCV-infected patients with end-stage chronic kidney disease after sustained virological response with direct-acting antiviral therapy
Martinez-Camprecios, Joan; (...); Buti, Maria
Article. 10.1016/j.gastrohep.2022.12.004. 2023
Long-term outcome after living donor liver transplantation compared to donation after brain death in autoimmune liver diseases: Experience from the European Liver Transplant Registry.
Heinemann M; (...); all the other contributing centers (www.eltr.org) and the European Liver and Int
Article. 10.1111/ajt.16864. 2022
Long-term prospective follow-up of a primary biliary cholangitis (PBC) multicenter cohort treated with Obeticholic Acid (OCA). Interaction effect of triple therapy with fibrates
Gomez-Dominguez, Elena; (...); Fernandez-Rodriguez, Conrado
Meeting Abstract. 2023
Long-term survival after living donor liver transplantation in primary sclerosing cholangitis
Liwinski, T; (...); Schramm, C
Meeting Abstract. 2021
Low penetrance of frequent ATP7B mutations explains the low prevalence of Wilson disease. Lessons from real-life registries.
Alonso-Castellano, Pablo; (...); Garcia-Villarreal, Luis
Article. 10.1016/j.dld.2024.09.002. 2024
MAGNETIC RESONANCE IMAGING-BASED BIOMARKER ACCURATELY IDENTIFIES PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS AND CLINICALLY SIGNIFICANT LIVER FIBROSIS: A MULTICENTER, INTERNATIONAL, VALIDATION STUDY
Arnouk, Joud; (...); Marti-Bonmati, Luis
Meeting Abstract. 2021
Main clinical characteristics and evolutionary events among patients suffering Wilson disease in Spain: first results from the Spanish Wilson registry
Marino, Zoe; (...); Castillo, Pilar
Meeting Abstract. 2023
Management of cytomegalovirus in adult solid organ transplant patients: GESITRA-IC-SEIMC, CIBERINFEC, and SET recommendations update.
Ruiz-Arabi, Elisa; (...); Aguado, Jose Maria
Article. 10.1016/j.trre.2024.100875. 2024
Management of Established Small-for-size Syndrome in Post Living Donor Liver Transplantation: Medical, Radiological, and Surgical Interventions: Guidelines From the ILTS-iLDLT-LTSI Consensus Conference.
Kirchner, Varvara A.; (...); Rela, Mohamed
Article. 10.1097/TP.0000000000004771. 2023
Management of flexible cavovarus foot in patients with Charcot-Marie-Tooth disease: midterm results.
Megías-Vericat JE; (...); Poveda-Andrés JL
Article. 2021
Manipulación de fármacos para su administración por gastrostomía endoscópica percutánea en pacientes con esclerosis lateral amiotrófica y nutrición enteral.
Vázquez Polo A; (...); Vázquez Costa JF
Article. 10.20960/nh.03946. 2022
Matching-Adjusted Indirect Comparison of Efficacy and Consumption of rVIII-SingleChain Versus Two Recombinant FVIII Products Used for Prophylactic Treatment of Adults/Adolescents with Severe Haemophilia A
Bonanad, S; (...); Santos, S
Article. 10.1007/s12325-021-01853-0. 2021
Metabolic Phenotyping in Prostate Cancer Using Multi-Omics Approaches.
Gomez-Cebrian, Nuria; (...); Puchades-Carrasco, Leonor
Article. 10.3390/cancers14030596. 2022
Metabolic syndrome before liver transplantation: does it have an impact on post liver transplantation outcomes?
Herreras Lopez, Julia; (...); Aguilera, Victoria
Article. 10.17235/reed.2022.8384/2021. 2022
Metabolomic analysis to discriminate drug-induced liver injury (DILI) phenotypes
Quintas, G; (...); Castell, JV
Article. 10.1007/s00204-021-03114-z. 2021
Mitochondrial bioenergetics boost macrophages activation promoting liver regeneration in metabolically compromised animals.
Goikoetxea-Usandizaga, Naroa; (...); Martínez-Chantar ML
Article. 10.1002/hep.32149. 2021
Mortality and Causes of Death After Liver Transplantation: Analysis of Sex Differences in a Large Nationwide Cohort.
Serrano MT; (...); Salcedo M
Article. 10.3389/ti.2022.10263. 2022
MRI-PDFF captures the whole spectrum of lipid composition beyond traditional histological evaluation of macrosteatosis
Marti-Aguado, David; (...); Marti-Bonmati, Luis
Meeting Abstract. 2023
mTOR inhibitors a potential predisposing factor for chronic hepatitis E: Results from the prospective collaborative CHES study (Chronic Hepatitis EScreening in patients with immune impairment and increased transaminases levels).
Riveiro-Barciela, Mar; (...); Esteban, Rafael
Article. 10.1016/j.gastrohep.2023.01.010. 2023
Multidrug resistant bacterial infections after liver transplantation: prevalence, impact and associated risk factors
Martin-Mateos, Rosa; (...); Albillos, Agustin
Meeting Abstract. 2022
Multidrug-resistant bacterial infections after liver transplantation: prevalence, impact, and risk factors
Martin-Mateos, R.; (...); Albillos, A.
Meeting Abstract. 2024
Multidrug-resistant bacterial infections after liver transplantation: prevalence, impact, and risk factors.
Martin-Mateos R; (...); Albillos A
Article. 10.1016/j.jhep.2024.02.023. 2024
Multi-institutional Analysis of Metastasis-directed Therapy with or Without Androgen Deprivation Therapy in Oligometastatic Castration-sensitive Prostate Cancer.
Deek MP; (...); Sweeney C
Article. 10.1016/j.euo.2024.03.010. 2024
Multi-Omic Approaches to Breast Cancer Metabolic Phenotyping: Applications in Diagnosis, Prognosis, and the Development of Novel Treatments
Gomez-Cebrian, N; (...); Pineda-Lucena, A
Review. 10.3390/cancers13184544. 2021
National Survey of the SEFH-2019: portfolio of services, healthcare activity, teaching and research in Hospital Pharmacy Services in Spain (vol 45, pg 32, 2021)
Perez-Encinas, Montserrat; (...); Angel Calleja-Hernandez, Miguel
Correction. 10.7399/fh.11740. 2021
National Survey on the Use of Mobile Applications in Patients with Hemophilia and Other Coagulopathies
Eduardo Megias, Juan; (...); Poveda Andres, Jose Luis
Meeting Abstract. 10.1182/blood-2022-169938. 2022
New challenges of advanced therapies.
Megías-Vericat JE; (...); Poveda Andrés JL
Article. 10.1016/j.farma.2023.11.008. 2024
New ERAS in liver transplantation - Past, present, and next steps
Hannon, Vivienne N.; (...); ERAS4OLT Org Working Grp
Article. 10.1111/ctr.14625. 2022
Non-alcoholic steatohepatitis as liver transplant indication: similarities and differences between a high and a low prevalence countries
Martinez-Arenas, L.; (...); Berenguer, M.
Meeting Abstract. 2022
Non-alcoholic steatohepatitis is also becoming a major liver transplant indication in Spain, a historically low risk area
Martinez-Arenas, Laura; (...); Berenguer, Marina
Meeting Abstract. 2022
Nutritional status in hepatic encephalopathy and transjugular intrahepatic portosystemic shunt-TIPS, and strategies to improve the outcomes
Review. 10.51821/86.2.11430. 2023
Obeticholic Acid and Fibrates in Primary Biliary Cholangitis: Comparative Effects in a Multicentric Observational Study.
Reig, A; (...); Pares, A
Article. 10.14309/ajg.0000000000001343. 2021
Observational study to evaluate discontinuation of monotherapy with cobicistat-boosted darunavir in patients with human immunodeficiency virus
Solana-Altabella, Antonio; (...); Poveda-Andres, Jose Luis
Article. 10.1097/MD.0000000000032208. 2022
Odronextamab in Patients with Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL): Results from a Prespecified Analysis of the Pivotal Phase II Study ELM-2
Kim, Won-Seog; (...); Walewski, Jan
Meeting Abstract. 10.1182/blood-2022-158406. 2022
ODs with a positive TPR conclusion, not subject to a conditional approval, and approved without requering a pass would be more likely to be reimbursed in Spain.
Poveda JL; (...); Badia X
Article. 10.1186/s13023-022-02610-4. 2023
Ofatumumab as part of reduced intensity conditioning in high risk B-cell lymphoma patients: final long-term analysis from a prospective multicenter Phase-II Trial
Cabrero M; (...); Caballero D
Article. 10.1038/s41409-023-02171-5. 2024
Omics-Based Approaches for the Characterization of Pompe Disease Metabolic Phenotypes
Gomez-Cebrian, Nuria; (...); Puchades-Carrasco, Leonor
Review. 10.3390/biology12091159. 2023
One-quarter of chronic hepatitis D patients reach HDV-RNA decline or undetectability during the natural course of the disease
Palom, A; (...); Buti, M
Article. 10.1111/apt.16485. 2021
Open wound and cutaneous fistulization after microwave ablation of hepatocarcinoma.
Ladron Abia, Pablo; (...); Aguilera, Victoria
Article. 10.17235/reed.2022.8663/2022. 2022
Optimal management of perioperative analgesia regarding immediate and short-term outcomes after liver transplantation - A systematic review, meta-analysis and expert panel recommendations
Sun, Li-Ying; (...); ERAS4OLT Org Working Grp
Review. 10.1111/ctr.14640. 2022
Optimization of treatment in patients with primary biliary cholangitis: Gamma-glutamyl transferase levels as an early prognostic marker for ursodeoxycholic acid response. Results from the ColHai registry
Fernandez-Gordon Sanchez, Flor M.; (...); Gomez-Dominguez, Elena
Meeting Abstract. 2024
OPTIMIZING MANAGEMENT AND OUTCOMES OF ACTIVATED PHOSPHOINOSITIDE 3-KINASE DELTA SYNDROME (APDS) IN SPAIN: BEWAYAPDS PROJECT
Flores-Moreno, S.; (...); Gil, A.
Meeting Abstract. 2024
OVERCOMING BARRIERS TO CARE FOR DELTA INFECTED PATIENTS
Carvalho-Gomes, Angela; (...); Berenguer, Marina
Meeting Abstract. 2022
Overcoming barriers to care for Delta infected patients
Bono, Ariadna; (...); Berenguer, Marina
Meeting Abstract. 2023
Overview of Cellular and Soluble Mediators in Systemic Inflammation Associated with Non-Alcoholic Fatty Liver Disease.
Marques, Patrice; (...); Sanz, Maria-Jesus
Article. 10.3390/ijms24032313. 2023
Paediatric solid organ transplant recipients (SOTR) demonstrate greater serological response to initial SARS-CoV-2 vaccination than adult SOTR, and comparable rates of antibody degradation
Pilar Ballester, Maria; (...); Nicastro, Emanuele
Meeting Abstract. 2024
Pancreatic steatosis and iron overload increases cardiovascular risk in non-alcoholic fatty liver disease.
Marti-Aguado D; (...); Marti-Bonmati L
Article. 10.3389/fendo.2023.1213441. 2023
Panel Sequencing for Clinically Oriented Variant Screening and Copy Number Detection in Chronic Lymphocytic Leukemia Patients
Ibanez, Mariam; (...); Luna I
Article. 10.3390/diagnostics12040953. 2022
Paracetamol vs. Ibuprofen in Preterm Infants With Hemodynamically Significant Patent Ductus Arteriosus: A Non-inferiority Randomized Clinical Trial Protocol (vol 8, 372, 2020)
Garcia-Robles, Ana; (...); Aguar Carrascosa, Marta
Correction. 10.3389/fped.2021.834454. 2022
Paradoxical Findings in Patients with Paroxysmal Nocturnal Hemoglobinuria Treated with C5 Inhibitors: Suboptimal Disease Control Perceived As Satisfactory
Gaya, Anna; (...); Vallejo, Carlos
Meeting Abstract. 10.1182/blood-2023-185939. 2023
Patient and health practitioner perceptions about the role of hospital pharmacists along the care continuum: the Fharmaconectados Project
Morillo-Verdugo, R; (...); Diaz-Olmo, J
Article. 10.7399/fh.11719. 2021
Patient and health practitioner perceptions about the role of hospital pharmacists along the care continuum: the Fharmaconectados Project.
Morillo-Verdugo R; (...); Díaz-Olmo J
Article. 2021
Peripheral T-cell lymphoma with a T follicular-helper phenotype: A different entity? Results of the Spanish Real-T study.
Martin Garcia-Sancho, Alejandro; (...); Cordoba, Raul
Article. 10.1111/bjh.18941. 2023
Pharmacogenetics in Response to Biological Agents in Inflammatory Bowel Disease: A Systematic Review.
Ballesta-Lopez, Octavio; (...); Poveda-Andres, Jose Luis
Article. 10.3390/ijms26041760. 2025
Pharmacometabolomics by NMR in Oncology: A Systematic Review.
Gómez-Cebrián N; (...); Pineda-Lucena A
Article. 10.3390/ph14101015. 2021
Pharmacotherapeutic management of advanced therapy medicinal products
Luis Poveda-Andres, Jose; (...); Valero-Garcia, Silvia
Article. 10.7399/fh.13036. 2022
Porto sinusoidal vascular liver disorder: natural history and long-term outcome
Magaz, Marta; (...); Garcia Pagan, Juan Carlos
Meeting Abstract. 2023
Porto-sinusoidal vascular liver disorder with portal hypertension: Natural History and Long-Term Outcome.
Magaz, Marta; (...); Garcia-Pagan, Juan Carlos
Article. 10.1016/j.jhep.2024.07.035. 2024
Post Living Donor Liver Transplantation Small-for-size Syndrome: Definitions, Timelines, Biochemical, and Clinical Factors for Diagnosis: Guidelines From the ILTS-iLDLT-LTSI Consensus Conference.
Kow, Alfred Wei Chieh; (...); Ikegami, Toru
Article. 10.1097/TP.0000000000004770. 2023
PREDICTION OF BIOCHEMICAL RESPONSE IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS TREATED WITH OBETICHOLIC ACID: DERIVATION AND EXTERNAL VALIDATION OF THE OCA RESPONSE SCORE (ORS)
De Vincentis, Antonio; (...); Carbone, Marco
Meeting Abstract. 2023
Predictive factors for decompensating events in patients with cirrhosis with primary biliary cholangitis under different lines of therapy.
Ampuero J; (...); Fernández-Rodríguez C
Article. 10.1097/HEP.0000000000000826. 2024
Predictive models of treatment benefit in patients with autoimmune hepatitis and decompensated cirrhosis at diagnosis
Arvaniti, Pinelopi; (...); Carlota Londono, Maria
Meeting Abstract. 2023
Preparation and administration of insulin infusions in neonatology: A national survey.
Garcia-Robles, Ana; (...); Aguar Carrascosa, Marta
Article. 10.1016/j.anpede.2020.06.015. 2021
Presence of good humanization practices in the healthcare of patients with rare diseases in Pharmacy Services
Company Albir MJ, Poveda Andrés JL, Edo Solsona MD
Article. 10.1016/j.farma.2023.06.0131130. 2024
Preventing Small-for-size Syndrome in Living Donor Liver Transplantation: Guidelines From the ILTS-iLDLT-LTSI Consensus Conference.
Hakeem AR; (...); Rela M
Article. 10.1097/TP.0000000000004769. 2023
Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2022 Clinical Practice Guideline.
Awan, Ahmed Arslan Yousuf; (...); Jadoul, Michel
Article. 10.7326/M23-2391. 2023
Primary and secondary immune thrombocytopenia (ITP): Time for a rethink.
Gonzalez-Lopez, Tomas Jose; (...); Fernandez-Fuertes, Fernando
Article. 10.1016/j.blre.2023.101112. 2023
Primary biliary cholangitis and SARS-CoV-2 infection: incidence, susceptibility and outcomes.
Ampuero J; (...); Molina E
Letter. 10.1136/gutjnl-2021-325700. 2021
Primary sclerosing cholangitis as an indication for liver transplantation. Results and conditioning factors: relationship with associated intestinal pathology
Fernandez, Ainhoa; (...); Salcedo, Magdalena
Meeting Abstract. 2023
Primary sclerosing cholangitis as an indication for liver transplantation. Results and conditioning factors: relationship with associated intestinal pathology
Fernandez-Yunquera, A.; (...); Salcedo, M. M.
Meeting Abstract. 2023
Primary Sclerosing Cholangitis: Gender Effects in Valencia's Low-Prevalence Region.
Minguez, Alejandro; (...); Berenguer, Marina
Article. 10.1007/s10620-024-08368-y. 2024
Profile of plasma microRNAs as a potential biomarker of Wilson's disease.
Sanchez-Monteagudo, Ana; (...); Espinos, Carmen
Article. 10.1007/s00535-024-02135-6. 2024
Prognostic Value of Serum Paraprotein Response Kinetics in Patients With Newly Diagnosed Multiple Myeloma.
Tamariz-Amador, Luis-Esteban; (...); Troconiz, Inaki F.
Article. 10.1016/j.clml.2022.04.024. 2022
Prognosticating hepatocellular carcinoma before and after liver transplantation with HepatoPredict
Silva, Silvia Gomes; (...); Cardoso, Joana
Meeting Abstract. 2024
Prophylaxis for tuberculosis and pneumocystis jirovecii does not seem necessary in patients with autoimmune hepatitis treated with corticosteroid therapy: spanish multicentre study
Diaz-Gonzalez, Alvaro; (...); Crespo, Javier
Meeting Abstract. 2024
Protocol for an International Living Donor Liver Transplant Registry ! LDLTregistry.org
Turner, B.; (...); Salinas, C. Hidalgo
Meeting Abstract. 2023
Real-life clinical practice in Spain in the setting of new drug availability for ITP treatment. A Delphi-based Spanish expert panel consensus.
Gonzalez-Lopez, Tomas Jose; (...); Jarque, Isidro
Article. 10.1080/09537104.2024.2336104. 2024
Real-life effectiveness of voxilaprevir/sofosbuvir/velpatasvir in hepatitis C patients previously treated with sofosbuvir/velpatasvir or glecaprevir/pibrentasvir
Ruiz-Cobo, Juan Carlos; (...); Lens, Sabela
Meeting Abstract. 2023
Real-World Characteristics and Outcome of Patients Treated With Single-Agent Ibrutinib for Chronic Lymphocytic Leukemia in Spain (IBRORS-LLC Study).
Abrisqueta, Pau; (...); Villanueva, Miguel
Article. 10.1016/j.clml.2021.07.022. 2021
Recommendations for the Clinical Approach to Immune Thrombocytopenia: Spanish ITP Working Group (GEPTI).
Mingot-Castellano, Maria Eva; (...); Pascual-Izquierdo, Cristina
Article. 10.3390/jcm12206422. 2023
Recommendations for the integral diagnosis of chronic viral hepatitis in a single analytical extraction.
Crespo, Javier; (...); Calleja, Jose Luis
Practice Guideline. 10.1016/j.gastrohep.2022.09.009. 2023
Recompensation following an episode of alcohol-associated hepatitis mostly occurs in the first year of follow-up and is related to Child-Pugh score, levels of GGT and platelets, and alcohol abstinence
Gratacos, Jordi; (...); Pose, Elisa
Meeting Abstract. 2023
Recovery of Uninvolved Heavy/Light Chain Pair Immunoparesis during Maintenance Is an Independent Prognostic Factor for Multiple Myeloma and Could Complement Prognosis Value of Minimal Residual Disease
Lakhwani, Sunil; (...); Hernandez, Miguel-Teodoro
Meeting Abstract. 10.1182/blood-2022-167247. 2022
Recovery of uninvolved heavy/light chain pair immunoparesis in newly diagnosed transplant-eligible myeloma patients complements the prognostic value of minimal residual disease detection.
Lakhwani S; (...); Hernández MT
Article. 10.3324/haematol.2023.284154. 2024
Recurrence of Hepatocellular Carcinoma after Liver Transplantation: Clinical Patterns and Hierarchy of Salvage Treatments
Giuliani, Tommaso; (...); Lopez-Andujar, Rafael
Article. 10.1159/000539460. 2024
Recurrent alcohol-associated hepatitis is common and is associated with increased mortality.
Gratacos-Gines, Jordi; (...); Pose, Elisa
Article. 10.1097/HEP.0000000000000825. 2024
Re-irradiation in NSCLC High-dose RT: Control, Survival and Toxicity
Germain, J.; (...); Conde, A.
Meeting Abstract. 2023
Relevancia de la anfotericina B liposomal en el tratamiento de las infecciones fúngicas invasoras en pacientes oncohematológicos.
García-Vidal C, Vázquez L, Jarque I
Article. 10.1016/j.riam.2021.03.001. 2021
Reproductive and pregnancy control in Wilson disease patients in Spain.
Romero-Gutiérrez M; (...); Mariño Z
Article. 10.1097/MEG.0000000000002831. 2024
Rising indication of non-alcoholic steatohepatitis as transplant indication in historically low risk areas
Martinez-Arenas, L.; (...); Berenguer, M.
Meeting Abstract. 2022
Risk of decompensated cirrhosis in patients with primary biliary cholangitis under first, second and third-line therapies
Lucena, Ana; (...); Ampuero, Javier
Meeting Abstract. 2023
Rivaroxaban improves survival and decompensation in cirrhotic patients with moderate liver dysfunction. Double-blind, placebocontrolled trial
Puente Sanchez, Angela; (...); Garcia Pagan, Juan Carlos
Meeting Abstract. 2023
SEOM-GOTEL clinical guidelines on diffuse large B cell lymphoma (2022).
Guma, Josep; (...); Provencio, Mariano
Article. 10.1007/s12094-023-03206-5. 2023
Serological response and breakthrough infection after COVID-19 vaccination in patients with cirrhosis and post-liver transplant.
Mehta, Gautam; (...); Jalan, Rajiv
Article. 10.1097/HC9.0000000000000273. 2023
Should we seek complete liver tests normalization in primary biliary cholangitis? Data from ColHai registry
Diaz-Gonzalez, Alvaro; (...); del Registro, Grupo
Meeting Abstract. 2022
Significant heterogeneity in the diagnosis and long-term management of Wilson disease: Results from a large multicenter Spanish study
Berenguer, Marina; (...); GEMHEP
Article. 10.1016/j.gastrohep.2022.10.018. 2023
SIMILAR POST-TRANSPLANT OUTCOMES USING DONORS AFTER CARDIAC DEATH WHEN APPLYING STRICT SELECTION CRITERIA
de la Varga, MF; (...); Aguilera, V
Meeting Abstract. 2021
Similar rates of liver transplantation (LT) for acute liver failure (ALF) but changes in patient profiles in a Spanish multicentre cohort
Conde, I.; (...); Aguilera, V.
Meeting Abstract. 2023
Simple score to assess cardiovascular risk post-liver transplantation
Di Maira, T; (...); Berenguer, M
Meeting Abstract. 2021
SIMPLE SCORE TO ASSESS CARDIOVASCULAR RISK POST-LIVER TRANSPLANTATION
Di Maira, Tommaso; (...); Berenguer, Marina
Meeting Abstract. 2022
Sinusoidal Obstruction Syndrome after Liver Transplantation: A Multicenter Observational Study.
Caballero-Marcos A; (...); Salcedo M
Article. 10.1002/lt.26452. 2022
SMPTall man lettering application in medication information systems as a quality and safety strategy in hospital organization
Iglesias Gomez, Ruben; (...); Poveda Andres, Jose Luis
Article. 10.1111/jcpt.13703. 2022
Survey to evaluate the implementation of the recommendations on the comprehensive diagnosis of viral hepatitis in a single extraction: where are we?
Cabezas, Joaquin; (...); Crespo, Javier
Meeting Abstract. 2023
SURVEY TO EVALUATE THE IMPLEMENTATION OF THE RECOMMENDATIONS ON THE COMPREHENSIVE DIAGNOSIS OF VIRAL HEPATITIS IN A SINGLE EXTRACTION: WHERE ARE WE?
Cabezas, Joaquin; (...); Crespo Garcia, Javier
Meeting Abstract. 2023
Sustained Recovery of Uninvolved Heavy/Light Chain Pair Immunoparesis during Maintenance Discriminates Patients with Sustained Negative Minimal Residual Disease
Lakhwani, Sunil; (...); Teodoro Hernandez Garcia, Miguel
Meeting Abstract. 10.1182/blood-2023-179452. 2023
Systematic Review of Pharmacogenetics of ABC and SLC Transporter Genes in Acute Myeloid Leukemia
Megías-Vericat JE; (...); Montesinos P
Review. 10.3390/pharmaceutics14040878. 2022
Technical Validation and Clinical Implications of Ultrasensitive PCR Approaches for EGFR-Thr790Met Mutation Detection in Pretreatment FFPE Samples and in Liquid Biopsies from Non-Small Cell Lung Cancer Patients
Simarro, Javier; (...); Palanca, Sarai
Article. 10.3390/ijms23158526. 2022
The association of salivary caffeine levels with serum concentrations in premature infants with apnea of prematurity
Garcia-Robles, Ana; (...); Saenz Gonzalez, Pilar
Article. 10.1007/s00431-022-04628-z. 2022
The concentration of HDV-RNA correlates with the probability of developing clinical events in patients with chronic hepatitis D
Palom, Adriana; (...); Buti, Maria
Meeting Abstract. 2024
The contribution of fenfluramine to the treatment of Dravet syndrome in Spain through Multi-Criteria Decision Analysis.
Gil-Nagel A; (...); Gil A
Article. 10.1016/j.yebeh.2022.108711. 2022
The global prospective observational study to evaluate the role of 'liver transplantation in patients with cirrhosis and severe acute-on-chronic liver failure (CHANCE)': study design, demographics and overall outcome
Gustot, Thierry; (...); Jalan, Rajiv
Meeting Abstract. 2024
The ILTS-SETH Consensus Conference on Extrahepatic Cancer and Liver Transplantation: Paving the Way.
Colmenero J, Berenguer M, Watt KD
Article. 10.1097/TP.0000000000003994. 2022
The impact of COVID-19 on liver transplant (LT) centers across the world during the first wave: a Multisociety Survey (EASL-ESOT/ELITA-ILTS)
Russo, FP; (...); Polak, W
Meeting Abstract. 2021
The interaction between metabolic syndrome and alcohol consumption after an episode of alcohol-associated hepatitis is associated with increased mortality: results from de spanish registry of alcohol-associated liver disease (REHALC)
Gratacos-Gines, Jordi; (...); Pose, Elisa
Meeting Abstract. 2024
THE PRESENCE OF METABOLIC SYNDROME BEFORE TRANSPLANTATION INCREASE THE RISK OF CARDIOVASCULAR EVENTS FOLLOWING LIVER TRANSPLANTATION
Herreras, J; (...); Aguilera, V
Meeting Abstract. 2021
The Reality of Inadequate Patient Care and the Need for a Global Action Framework in Organ Donation and Transplantation.
Domínguez-Gil B; (...); Delmonico FL
Article. 10.1097/TP.0000000000004186. 2022
The role of early extubation on short-term outcomes after liver transplantation - A systematic review, meta-analysis and expert recommendations
Tinguely, Pascale; (...); ERAS4OLT Org Working Grp
Review. 10.1111/ctr.14642. 2022
The role of HBIG in real life for patients undergoing liver transplantation due to HDV-related cirrhosis
Rodriguez-Tajes, Sergio; (...); Forns, Xavier
Article. 10.1111/liv.15777. 2024
The role of preoperative optimization of the nutritional status on the improvement of short-term outcomes after liver transplantation? A review of the literature and expert panel recommendations
Victor, David W.; (...); ERAS4OLT Org Working Grp
Article. 10.1111/ctr.14647. 2022
The value of the reflective discussion in decision-making using multi-criteria decision analysis (MCDA): an example of determining the value contribution of tabelecleucel for the treatment of the Epstein Barr virus-positive post-transplant lymphoproliferative disease (EBV+ PTLD).
Badia, Xavier; (...); Valles, Joan-Antoni
Article. 10.1186/s13023-024-03324-5. 2024
Toxic-metabolic encephalopathy induced by metronidazole and disulfiram: classics never die.
Chovi-Trull, Maria; (...); Poveda-Andres, Jose Luis
Article. 10.1136/ejhpharm-2024-004184. 2024
Transaminase Pattern Over Time Is Not Associated with a More Aggressive Hepatic Evolution: Results from the AEEH Wilson Registry
Berenguer, Marina; (...); Marino, Zoe
Meeting Abstract. 2024
Transplantation: A Priority in the Healthcare Agenda.
Muller E; (...); Potena L
Article. 10.1097/TP.0000000000005182. 2025
Trends in liver transplantation for acute liver failure. A Spanish multicenter study
Conde, Isabel; (...); Berenguer, Marina
Meeting Abstract. 2022
Trends in liver transplantation for acute liver failure: a Spanish multicenter study
Conde, I.; (...); Berenguer, M.
Meeting Abstract. 2022
Use of HBsAg-positive donors in liver transplantation: an ILTS-EASLAASLD multisociety survey
Vinaixa, C.; (...); Terrault, N.
Meeting Abstract. 2024
Use of HBsAg-positive donors in liver transplantation: An ILTS-EASL-AASLD multisociety survey.
Vinaixa, Carmen; (...); Berenguer, Marina
Article. 10.1097/LVT.0000000000000432. 2024
Validation of MELD3.0 in 2 centers from different continents.
Tejedor M; (...); Berenguer M
Article. 10.1097/HC9.0000000000000504. 2024
Validation of MELD3.0 in two centres from different continents
Tejedor Bravo, Marta; (...); Berenguer, Marina
Meeting Abstract. 2023
Validation of MELD3.0 in two centres from different continents
Tejedor, M.; (...); Berenguer, M.
Meeting Abstract. 2023
Validation of the gender-equity model for liver allocation (GEMA) in a nationwide cohort of liver transplant candidates in Spain
Rodriguez-Peralvarez, Manuel; (...); Gastaca, Mikel
Meeting Abstract. 2024
Validation of the liver frailty index as an adverse outcome predictor in the spanish liver transplant setting. Results from a spanish multicentre prospective cohort study.
Puchades, L.; (...); Berenguer, M.
Meeting Abstract. 2023
VALUE CRITERIA FOR OUTCOMES BASED MANAGED ENTRY AGREEMENT OF CAR-T IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA (RRMM) THROUGH MCDA
Poveda, J. L.; (...); Lizan, L.
Meeting Abstract. 2023
Variation in global living donor liver transplant surgical technique - early data from the International Living Donor Liver Transplant Registry (LDLTregistry.org)
Kantsedikas, I.; (...); Rela, M.
Meeting Abstract. 2024
Variation in global living donor liver transplant surgical technique: Early data from the International Living Donor Liver Transplant Registry
Kantsedikas, Ilya; (...); Rela, Mohamed
Meeting Abstract. 10.1097/01.tp.0001066152.18661.c6. 2024
Very low access to early liver transplantation (LT) for acute alcoholic hepatitis (AAH) in a setting of social psychiatric contraindications
Garcia Garcia, S.; (...); Aguilera, V.
Meeting Abstract. 2023
Waiting time dictates impact of frailty: A Spanish multicenter prospective study.
Puchades, Lorena; (...); Berenguer, Marina
Article. 10.1016/j.jhepr.2023.100840. 2023
What is the optimal management of thromboprophylaxis after liver transplantation regarding prevention of bleeding, hepatic artery, or portal vein thrombosis? A systematic review of the literature and expert panel recommendations
Kirchner, Varvara A.; (...); ERAS4OLT Org Working Grp
Review. 2022
Wilson's Disease: Facing the Challenge of Diagnosing a Rare Disease
Sánchez-Monteagudo A; (...); Espinós C
Review. 10.3390/biomedicines9091100. 2021
Women are also disadvantaged in accessing transplant outside the United States: analysis of the spanish liver transplantation registry
Tejedor, Marta; (...); Berenguer, Marina
Meeting Abstract. 2024
Women Are Also Disadvantaged in Accessing Transplant Outside the United States: Analysis of the Spanish Liver Transplantation Registry.
Tejedor, Marta; (...); Berenguer, Marina
Article. 10.3389/ti.2024.12732. 2024
Worldwide variations in COVID-19 vaccination policies and practices in liver transplant settings: results of a multi-society global survey.
Di Maira, Tommaso; (...); Berenguer, Marina
Article. 10.3389/frtra.2023.1332616. 2023